Click here to view the CareFirst BCBS Blue Cross Blue Shield Medical Policy Updates »…
BCBS Kansas City Medical Policy Updates – February 2023
Click here to view the Blue Cross Blue Shield BCBS Kansas City Medical Policy Updates »
February 2023 BCBS Kansas City Medical Policy Updates:
- Actemra (tocilizumab)
- Acupuncture for Pain ManagementNausea and Vomitingand Opioid Dependence
- ADHD Stimulant ST Policy
- Advanced Therapies for Pharmacologic Treatment of Pulmonary Arterial Hypertension
- Advanced Therapies for Pharmacological Treatment of Pulmonary Arterial Hypertension – MA Only
- Amniotic Membrane and Amniotic Fluid Injections
- Anorexiants
- Autografts and Allografts in the Treatment of Focal Articular Cartilage Lesions
- Botulinum Toxin
- Botulinum Toxin – MA Only
- Cialis (tadalafil) for Benign Prostatic Hyperplasia
- Cosentyx (secukinumab)
- Dojolvi (triheptanoin)
- Dynamic Spinal Visualization
- Empaveli (pegcetacoplan)
- Enbrel (etanercept)
- Esbriet (pirfenidone)
- Filgrastim (NeupogenGranixZarxioNivestym)
- Focal Treatments for Prostate Cancer
- Galafold (migalastat)
- Hematopoietic Stem-Cell Transplantation for Plasma Cell DyscrasiasIncluding Multiple Myeloma and POEMS Syndrome
- Herceptin (trastuzumab) and Biosimilars
- Hetlioz (tasimelteon)
- Ilumya (tildrakizumab-asmn)
- Isolated Small Bowel Transplant
- Kevzara (sarilumab)
- Kineret (anakinra)
- Laser Interstitial Thermal Therapy for Neurological Conditions
- Libtayo (cemiplimab-rwlc) – MA Only
- Liposuction for Lipedema and Lymphedema
- Microprocessor Controlled Prostheses for the Lower Limb
- Miscellaneous Investigational Procedures
- Mulpleta (lusutrombopag)
- Nucala (mepolizumab)
- Olumiant (baricitinib)
- Onpattro (patisiran)
- Orencia IV SQ (abatacept)
- Orilissa (elagolix)
- Orthoptic Training for the Treatment of Vision or Learning Disabilities
- Pegfilgrastim (Neulasta Fulphila Nyvepria Udenyca Ziextenzo)
- Pelvic Floor Stimulation as a Treatment of Urinary and Fecal Incontinence
- Poteligeo (mogamulizmuab-kpkc)
- Radiofrequency Coblation Tenotomy for Musculoskeletal Conditions
- Retinal Prosthesis
- Rituxan (rituximab)
- Rybrevant (amivantamab-vmjw)
- Siliq (brodalumab)
- Skyrizi (risankizumab-rzaa)
- Stelara (ustekinumab)
- Step Therapy Policy
- Sunosi (solriamfetol)
- Takhzyro (lanadelumab)
- Thyroid Disease Testing
- Transcatheter Aortic-Valve Implantation for Aortic Stenosis
- Transcatheter Pulmonary Valve Implantation
- Treatment of Nasal Valve Collapse
- Verkazia (cyclosporine ophthalmic emulsion 01%)
- Xpovio (selinexor)
Click here to view the Blue Cross Blue Shield BCBS Kansas City Medical Policy Updates »
Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.
Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!
Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.
Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.
Related Posts
